Chronic Obstructive Pulmonary Disease, Neutrophils and Bacterial Infection: A Complex Web Involving IL-17 and IL-22 Unravels

by Dave Singh
Published 2015-11-01

Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects

by Dave Singh
Published 2020-07-01

Impact factor and its role in academic promotion

by Richard Russell, Dave Singh
Published 2009-07-01

The Human Virome Protein Cluster Database (HVPC): A Human Viral Metagenomic Database for Diversity and Function Annotation

by Ali H. A. Elbehery, Judith Feichtmayer, Dave Singh, Dave Singh, Christian Griebler, Li Deng
Published 2018-05-01

Changes in pneumatization of the maxillary air sinuses in Korean adults following biomimetic oral appliance therapy

by G. Dave Singh, Hee Nam Kim
Published 2021-04-01

Type‐2 airway inflammation in mild asthma patients with high blood eosinophils and high fractional exhaled nitric oxide

by Thomas Southworth, Marleen Van Geest, Dave Singh
Published 2021-07-01

The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD

by James Dean, Catalina Panainte, Naimat Khan, Dave Singh
Published 2020-12-01

Use of concomitant inhaled corticosteroids: pooled data from two phase III studies of aclidinium plus formoterol in COPD

by Anthony D’Urzo, Dave Singh, Esther Garcia Gil
Published 2017-02-01

COVID-19 and COPD: a narrative review of the basic science and clinical outcomes

by Andrew Higham, Alexander Mathioudakis, Jørgen Vestbo, Dave Singh
Published 2020-11-01

Efficacy and safety of tiotropium Respimat® SMI in COPD in two 1-year randomized studies

by Eric Bateman, Dave Singh, David Smith, et al
Published 2010-06-01

Multiple flow rate modelling of nitric oxide in COPD – methodological concerns

by Kay Roy, Zoe Borrill, Andrew Hazel, Jorgen Vestbo, Dave Singh
Published 2006-12-01

A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD

by Dave Singh, Fernando J. Martinez, Henrik Watz, Thomas Bengtsson, Brian T. Maurer
Published 2020-02-01

The pathology of small airways disease in COPD: historical aspects and future directions

by Andrew Higham, Anne Marie Quinn, José Eduardo D. Cançado, Dave Singh
Published 2019-03-01

Mechanisms of corticosteroid insensitivity in COPD alveolar macrophages exposed to NTHi

by Rana M. Khalaf, Simon R. Lea, Hannah J. Metcalfe, Dave Singh
Published 2017-04-01

The dose response of inhaled LPS challenge in healthy subjects

by Alex Mulvanny, Natalie Jackson, Caroline Pattwell, Sophie Wolosianka, Thomas Southworth, Dave Singh
Published 2018-06-01

Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base

by Anthony D. D’Urzo, Dave Singh, James F. Donohue, Kenneth R. Chapman
Published 2019-05-01

Down regulation of T cell receptor expression in COPD pulmonary CD8 cells.

by Seamus Grundy, Jonathan Plumb, Simon Lea, Manminder Kaur, David Ray, Dave Singh
Published 2013-01-01

Weighing the evidence for pharmacological treatment interventions in mild COPD; a narrative perspective

by Dave Singh, Anthony D. D’Urzo, James F. Donohue, Edward M. Kerwin
Published 2019-07-01

Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma

by Umme Kolsum, Arjun Ravi, Paul Hitchen, Satyanarayana Maddi, Thomas Southworth, Dave Singh
Published 2017-04-01

Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study

by Dave Singh, Aida Emirova, Catherine Francisco, Debora Santoro, Mirco Govoni, Marie Anna Nandeuil
Published 2020-09-01